You just read:

Boehringer Ingelheim Launches Observational Study on Management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate mesylate)

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Mar 23, 2016, 08:00 ET